Our Experts

Physician Profile

412-692-6740 Phone
412-692-6752 Fax

Paul Szabolcs, MD

Paul Szabolcs, MD
Job Title Chief, Division of Blood and Marrow Transplantation and Cellular Therapies
Job Title Professor, Pediatrics, University of Pittsburgh School of Medicine
4401 Penn Avenue, Suite Floor 9
Pittsburgh, PA 15224
412-692-6740 Phone
412-692-6752 Fax

Education and Training

Medical School:

1985 Semmelweis University School of Medicine, Budapest, Hungary 


1990 Pediatrics, Bellevue Hospital, New York University School of Medicine


1993 Hematology/Oncology/Bone Marrow Transplantation, Memorial Sloan-Kettering Cancer Center (MSKCC)/Cornell University Medical College

Academic Appointments:

2006-2011 Associate Professor of Pediatrics, Duke University School of Medicine

1998-2006 Assistant Professor of Pediatrics, Duke University School of Medicine

1994-1998 Instructor in Pediatrics, MSKCC

1993-1997 Guest Investigator, Research Associate, The Rockefeller University


  • American Society of Hematology
  • American Society for Blood & Marrow Transplantation
  • American Association of Immunologists
  • American Academy of Pediatrics
  • Center for International Blood and Transplant Research (CIBMTR): Immune Deficiencies/Inborn Errors Working Committee
  • CIBMTR: Graft-vs-Host Disease Working Committee
  • International Society for Cellular Therapy (ISCT): Immunotherapy and Dendritic Cell Committee
  • Society for Pediatric Research (SPR) Member
  • Co-Chair, CIBMTR: Infection and Immune Reconstitution Working Committee
  • Clinical Immunology Society

Board Certifications

  • American Board of Pediatrics
  • Pediatric Hematology-Oncology, Sub-Board of American Board of Pediatrics


  • 2000 Lisa Stafford Memorial Research Prize, Duke University Comprehensive Cancer Center, Durham, N.C.
  • 1980 First Prize for Critical Thesis, Human globin genes, Pecs University of Medical Sciences, Pecs, Hungary
  • 1980 Elected "Best Student of the Year," Pecs University of Medical Sciences, Pecs, Hungary


  • Szabolcs P, Buckley RH, Davis RD, Moffet J, Voynow J, Antony J, Chen X, Sempowski GD, Zaas DW. Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor. J Allergy Clin Immunol. 2014 Sep 24. pii: S0091-6749(14)01112-9.
  • Parikh SH, Mendizabal A, Benjamin CL, Komanduri KV, Antony J, Petrovic A, Hale G, Driscoll TA, Martin PL, Page KM, Flickinger K, Moffet J, Niedzwiecki D, Kurtzberg J, Szabolcs P. A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant. 2014 Mar;20(3):326-36.
  • Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Pai SY, Ballard B, Bauer SC, Bleesing JJ, Boyle M, Brower A, Buckley RH, van der Burg M, Burroughs LM, Candotti F, Cant AJ, Chatila T, Cunningham-Rundles C, Dinauer MC, Dvorak CC, Filipovich AH, Fleisher TA, Bobby Gaspar H, Gungor T, Haddad E, Hovermale E, Huang F, Hurley A, Hurley M, Iyengar S, Kang EM, Logan BR, Long-Boyle JR, Malech HL, McGhee SA, Modell F, Modell V, Ochs HD, O'Reilly RJ, Parkman R, Rawlings DJ, Routes JM, Shearer WT, Small TN, Smith H, Sullivan KE, Szabolcs P, Thrasher A, Torgerson TR, Veys P, Weinberg K, Zuniga-Pflucker JC; workshop participants. Primary Immune Deficiency Treatment Consortium (PIDTC) report. J Allergy Clin Immunol. 2014 Feb;133(2):335-47. 

Research Interests

  • Understanding the biology of immune reconstitution, tolerance  and alloreactivity after cord blood and bone marrow transplantation
  • Immunotherapy strategies to prevent or treat leukemia relapse after cord blood transplantation
  • Crohn’s disease and other autoimmune diseases
  • Krabbe disease and other leukodystrophies
  • MPS syndromes, high-risk leukemias

Clinical Specialties

  • Development of novel reduced toxicity transplant conditioning regimens to improve the safety of cord blood transplantation for children with nonmalignant diseases or with advanced leukemias
  • Combining unrelated donor bone marrow transplantation with lung transplantation for curative treatment of rare immune  and other inherited disorders resulting in pulmonary failure 

Active Research Projects / Grants

  • Immune Monitoring Core Laboratory for BMT CTN 05-01 Trial
  • Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation
  • Ancillary Studies in Clinical Trials: Immune Reconstitution After Cord Blood Transplantation
Last Update
December 16, 2014
  • Increase/Decrease Text Size
  • Print This Page
Last Update
December 16, 2014